A perspective view of sodium iodide symporter research and its clinical implications

G Riesco-Eizaguirre… - European Journal of …, 2006 - academic.oup.com
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates
active iodide transport into the thyroid gland and into several extrathyroidal tissues, in …

The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies

AR Penheiter, SJ Russell, SK Carlson - Current gene therapy, 2012 - ingentaconnect.com
Preclinical and clinical tomographic imaging systems increasingly are being utilized for non-
invasive imaging of reporter gene products to reveal the distribution of molecular …

Current and potential treatments for cervical cancer

G PC Yee, P de Souza… - Current cancer drug …, 2013 - ingentaconnect.com
Cervical cancer is the third most common carcinoma in women worldwide. Despite
increasing efforts to improve therapy in this disease, a significant proportion of women still …

Human reporter genes: potential use in clinical studies

I Serganova, V Ponomarev, R Blasberg - Nuclear medicine and biology, 2007 - Elsevier
The clinical application of positron-emission-tomography-based reporter gene imaging will
expand over the next several years. The translation of reporter gene imaging technology into …

Detecting tumor metastases: the road to therapy starts here

ME Menezes, SK Das, I Minn, L Emdad… - Advances in cancer …, 2016 - Elsevier
Metastasis is the complex process by which primary tumor cells migrate and establish
secondary tumors in an adjacent or distant location in the body. Early detection of metastatic …

A novel orally active inverse agonist of estrogen-related receptor gamma (ERRγ), DN200434, a booster of NIS in anaplastic thyroid cancer

TD Singh, J Song, J Kim, J Chin, HD Ji, JE Lee… - Clinical Cancer …, 2019 - AACR
Purpose: New strategies to restore sodium iodide symporter (NIS) expression and function
in radioiodine therapy–refractive anaplastic thyroid cancers (ATCs) are urgently required …

Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model

KI Kim, SJ Jang, JH Park, YJ Lee, TS Lee… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Copper is an essential cofactor for a variety of biochemical processes including oxidative
phosphorylation, cellular antioxidant activity, and elimination of free radicals. The copper …

Sodium Iodide Symporter (NIS)-Mediated Radionuclide (131I, 188Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene …

K Klutz, MJ Willhauck, N Wunderlich, C Zach… - Human gene …, 2011 - liebertpub.com
We reported the therapeutic efficacy of 131I in hepatocellular carcinoma (HCC) cells stably
expressing the sodium iodide symporter (NIS) under the control of the tumor-specific α …

Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression

MJ Willhauck, BR Sharif Samani… - The Journal of …, 2007 - academic.oup.com
Context: We reported recently the induction of iodide accumulation in prostate cancer cells
(LNCaP) by prostate-specific antigen promoter-directed sodium iodide symporter (NIS) …

Pharmacokinetics and dosimetry of 188Re-pharmaceuticals

G Ferro-Flores, CA de Murphy - Advanced drug delivery reviews, 2008 - Elsevier
The main objective of this review is to apportion current and new insight into the
biodistribution, radiopharmacokinetics, dosimetry and cell targeting of rhenium-188 labeled …